Sheryl Kane
Overview
Explore the profile of Sheryl Kane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rossom R, Crain A, Bart G, Richards J, Boggs J, OConnor P, et al.
AJPM Focus
. 2024 Nov;
3(6):100280.
PMID: 39605784
Introduction: Individuals with opioid use disorder are at elevated suicide risk, but systematic screening in this population is rarely done. This study assessed the effects of targeted clinical decision support...
2.
Hooker S, Starkey C, Bart G, Rossom R, Kane S, Olson A
BMC Prim Care
. 2024 Oct;
25(1):361.
PMID: 39394565
Background: Medications for opioid use disorder (MOUD), including buprenorphine, are effective treatments for opioid use disorder (OUD) and reduce risk for overdose and death. Buprenorphine can be prescribed in outpatient...
3.
Michalowicz B, Anderson J, Kottke T, Dehmer S, Worley D, Kane S, et al.
PLoS One
. 2023 Aug;
18(8):e0290028.
PMID: 37578943
Introduction: Periodontitis is a common oral disease associated with coronary artery disease (CAD), cerebrovascular disease (CBVD) and type 2 diabetes (T2D). We studied if periodontitis treatment improves clinical outcomes and...
4.
Hooker S, Crain A, LaFrance A, Kane S, Fokuo J, Bart G, et al.
Addict Sci Clin Pract
. 2023 Feb;
18(1):10.
PMID: 36774521
Background: Many primary care clinicians (PCCs) hold stigma toward people with opioid use disorder (OUD), which may be a barrier to care. Few interventions exist to address PCC stigma toward...
5.
Hooker S, Truitt A, Anderson J, Kane S, OConnor P, Sperl-Hillen J
Clin Diabetes
. 2022 Nov;
40(4):442-448.
PMID: 36385973
The coronavirus disease 2019 (COVID-19) pandemic instigated major changes in care delivery, but our understanding of how the rapid transition from in-person to telehealth encounters affected the care of patients...
6.
Hooker S, OConnor P, Sperl-Hillen J, Crain A, Ohnsorg K, Kane S, et al.
J Psychosom Res
. 2022 Apr;
158:110920.
PMID: 35461074
Objective: This study assessed the relationship of both depression diagnosis and clinically significant depressive symptoms with individual cardiovascular risk factors and estimated total cardiovascular risk in primary care patients. Methods:...
7.
Rindal D, Asche S, Kane S, Truitt A, Worley D, Davin L, et al.
J Pain Res
. 2021 Oct;
14:3309-3319.
PMID: 34707399
Introduction: Reports examining opioid prescribing for dental conditions are limited and do not examine patient-level factors. This study examines the association of patient age, sex, race, ethnicity, Medicaid coverage, and...
8.
Chen J, Poulaki V, Kim S, Eldred W, Kane S, Gingerich M, et al.
Transl Vis Sci Technol
. 2020 Aug;
9(5):19.
PMID: 32821491
Purpose: This work was motivated by the goals of demonstrating methods to fabricate and implant large numbers of penetrating arrays into the retina and the feasibility of extraction. Methods: Arrays...
9.
Tokede O, Walji M, Ramoni R, Rindal D, Worley D, Hebballi N, et al.
J Patient Saf
. 2017 Dec;
17(8):e1080-e1087.
PMID: 29206706
Background: Preventable medical errors in hospital settings are the third leading cause of deaths in the United States. However, less is known about harm that occurs in patients in outpatient...
10.
Pawloski P, Thomas A, Kane S, Vazquez-Benitez G, Shapiro G, Lyman G
J Am Med Inform Assoc
. 2016 Sep;
24(e1):e129-e135.
PMID: 27638907
Objectives: Clinical guidelines recommending the use of myeloid growth factors are largely based on the prescribed chemotherapy regimen. The guidelines suggest that oncologists consider patient-specific characteristics when prescribing granulocyte-colony stimulating...